Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system

Pharmaceutical Research

Volumn 27, Issue 5, 2010, Pages 767-774

  Lee, Jangwook ^a   Bhang, Suk Ho ^b   Park, Honghyun ^a   Kim, Byung Soo ^b   Yong Lee, Kuen ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Ischemic hindlimb model; Localized delivery; Microsphere hydrogel combination system; Therapeutic angiogenesis; Vascular endothelial growth factor

Indexed keywords

ALGINIC ACID; MICROSPHERE; POLYGLACTIN; RECOMBINANT VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; FEMALE; HINDLIMB; HYDROGEL; LEG MUSCLE; LIMB ISCHEMIA; MOUSE; MUSCLE ISCHEMIA; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

ALGINATES; ANGIOGENESIS MODULATING AGENTS; ANIMALS; BLOTTING, WESTERN; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; FEMALE; HINDLIMB; HYDROGELS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LACTIC ACID; MICE; MICE, NUDE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953259887     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0067-0     Document Type: Article

References (35)

1. Lange R, Weipert J, Homann M, Mendier N, Paek SU, Holper K, et al. Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2001;71:S365-7. (Pubitemid 32436998)
2. Cutler JA, Thom TJ, Roccella E. Leading causes of death in the United States. JAMA. 2006;295:383-384 (Pubitemid 43144967)
3. Miura SI, Saku K. Regulation of angiogenesis and angiogenic factors by cardiovascular medications. Curr Pharm Design. 2007;13:2113-2117 (Pubitemid 47040492)
4. Schmidt A, Brixius K, Bloch W Endothelial precursor cell migration during vasculogenesis. Circ Res. 2007;101:125-136 (Pubitemid 47196580)
5. Chu Y, Miller JD, Heistad DD. Gene therapy for stroke: 2006 overview. Curr Hypertens Rep. 2007;9:19-24.
6. Asahara T, Bauters C, Zheng L, Takeshita S, Bunting S, Ferrara N. Synergistic effect of vascular endothelial growth-factor and basic fibroblast growth-factor on angiogenesis in-vivo. Circulation. 1995;92:365-371
7. Baffour R, Berman J, Garb J, Rhee S, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vase Surg. 1992;16:181-191
8. Morishita R, Nakamura S, Hayashi S-I, Taniyama Y, Moriguchi A, Nagano T, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999;33:1379-1384 (Pubitemid 29282658)
9. Shyu K-G, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1. but not angiopoietin-2 augments revascularization in. the rabbit ischemic hindlimb. Circulation. 1998;98:2081-2087 (Pubitemid 28512235)
10. Su E, Cioffi C, Stefansson S, Mittereder N, Garay M, Hreniuk D. Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol-Heart Circul Physiol. 2003;284: H1.429-40. (Pubitemid 36348607)
11. Ahn A, Frishman W, Gutwein A, Passeri J, Nelson M. Therapeutic angiogenesis: a new treatment approach for ischemic heart diseasepart I. Cardiol Rev. 2008;16:163-171
12. Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, et al. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol. 2001;37:616-623 (Pubitemid 32147279)
13. Takeshita S, Zheng L, Brogi E, Kearney M, Pu L, Bunting S. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-670 (Pubitemid 24072807)
14. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF(165) after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-1123
15. Epstein SE, Kornowski R, Fuchs S, Dvorak HF. Angiogenesis therapy: Amidst the hype, the neglected potential for serious side effects. Circulation. 2001;104:115-119 (Pubitemid 32623299)
16. Morishita M, Peppas NA. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today. 2006;11:905-910
17. Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Contol Release. 2007;121: 91-99 (Pubitemid 47126068)
18. Hiemstra C, Zhong ZY, van. Steenbergen MJ, Hennink WE, Jan FJ. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. J Control Release. 2007;122:71-78
19. Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998;31:267-285
20. Anderson JM, Shive MS. Biodegradation, and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24.
21. Lee KY, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release. 2003;87:49-56. (Pubitemid 36255446)
22. Lee J, Lee KY Injectable microsphere/hydrogel combination systems for localized protein delivery. Macromol Biosci. 2009;9:671-676
23. Lee J, Tan CY, Lee S-K, Kim Y-H, Lee KY Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system, for the treatment of myocardial infarction. J Control Release. 2009;137:96-202.
24. Lee J, Lee KY local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm Res. 2009;26:1739-1744
25. Yang Y-Y, Chung T-S, Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials. 2001;22:231-241
26. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Amano K, Iba O, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vase Biol. 2002;22:1804-1810 (Pubitemid 35315765)
27. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H, et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc Res. 2002;53:993-1001. (Pubitemid 34261037)
28. Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K, et al. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med. 2002;4:371-380 (Pubitemid 40277174)
29. Jeon O, Kang S-W, Lim H-W, Hyung Chung J, Kim B-S. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials. 2006;27:1598-1607 (Pubitemid 41739585)
30. Tabata Y, Miyao M, Ozeki M, Ikada Y Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci-Polym Ed. 2000;11:915-930
31. Tae G, Scatena M, Stayton P, Hoffman A. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci-Polym Ed. 2006;17:187-197 (Pubitemid 44069724)
32. Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release. 2007;117:68-79. (Pubitemid 46164863)
33. Silva EA, Mooney DJ. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thrombos Haemost. 2007;5:590-598
34. Lewandowski TA, Ponce RA, Charleston JS, Hong S, Faustman EM. Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis. Dev Brain Res. 2003;141: 117-128 (Pubitemid 36321797)
35. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15:490-495